Augmentation of hemoglobin synthesis by S-phase specific drugs in the K562 cell line.
Dean
A
A
Wu
Y J
YJ
Ley
T
T
Fordis
C M
CM
Schechter
A N
AN
D000328:Adult; D001374:Azacitidine / Q000627:therapeutic use; D002460:Cell Line; D003561:Cytarabine / Q000627:therapeutic use; D004262:DNA Restriction Enzymes / Q000378:metabolism; D019003:Deoxyribonuclease HpaII; D005319:Fetal Hemoglobin / Q000096:biosynthesis* / Q000235:genetics; D005914:Globins / Q000096:biosynthesis; D006453:Hemoglobinopathies / Q000188:drug therapy*; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007399:Interphase / Q000187:drug effects*; D007700:Kinetics; D014158:Transcription, Genetic / Q000187:drug effects
D003561:Cytarabine; D005914:Globins; D005319:Fetal Hemoglobin; D004262:DNA Restriction Enzymes; D019003:Deoxyribonuclease HpaII; D001374:Azacitidine; D006918:Hydroxyurea